fecal DNA testing

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

Notes

  • cost: $600 (2014)

More general terms

More specific terms

References

  1. 1.0 1.1 1.2 Journal Watch 25(2):13, 2005 Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME; Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004 Dec 23;351(26):2704-14. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15616205
  2. Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet. 2002 Feb 2;359(9304):403-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11844514
  3. 3.0 3.1 3.2 Imperiale TF et al Multitarget Stool DNA Testing for Colorectal-Cancer Screening. N Engl J Med. March 18, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24645800 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1311194
    Robertson DJ and Dominitz JA Stool DNA and Colorectal-Cancer Screening. N Engl J Med. March 18, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24645801 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1400092
  4. Carethers JM JAMA Diagnostic Test Interpretation Stool-Based Screening Tests for Colorectal Cancer JAMA. Published online February 17, 2023 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36800187 https://jamanetwork.com/journals/jama/fullarticle/2801813